217 related articles for article (PubMed ID: 31489472)
1. Feasibility, safety, and long-term efficacy of stereotactic radiofrequency ablation for tumors adjacent to the diaphragm in the hepatic dome: a case-control study.
Schullian P; Putzer D; Laimer G; Levy E; Bale R
Eur Radiol; 2020 Feb; 30(2):950-960. PubMed ID: 31489472
[TBL] [Abstract][Full Text] [Related]
2. Percutaneous radiofrequency ablation with artificial ascites for hepatocellular carcinoma in the hepatic dome: initial experience.
Rhim H; Lim HK; Kim YS; Choi D
AJR Am J Roentgenol; 2008 Jan; 190(1):91-8. PubMed ID: 18094298
[TBL] [Abstract][Full Text] [Related]
3. Laparoscopic vs computerized tomography-guided radiofrequency ablation for large hepatic hemangiomas abutting the diaphragm.
Gao J; Kong J; Ding XM; Ke S; Niu HG; Xin ZH; Ning CM; Guo SG; Li XL; Zhang L; Dong YH; Sun WB
World J Gastroenterol; 2015 May; 21(19):5941-9. PubMed ID: 26019459
[TBL] [Abstract][Full Text] [Related]
4. Stereotactic radiofrequency ablation of subcardiac hepatocellular carcinoma: a case-control study.
Schullian P; Johnston EW; Putzer D; Eberle G; Laimer G; Bale R
Int J Hyperthermia; 2019; 36(1):876-885. PubMed ID: 31462110
[No Abstract] [Full Text] [Related]
5. Stereotactic radiofrequency ablation as first-line treatment of recurrent HCC following hepatic resection.
Schullian P; Laimer G; Putzer D; Levy E; Braunwarth E; Stättner S; Bale R
Eur J Surg Oncol; 2020 Aug; 46(8):1503-1509. PubMed ID: 32222261
[TBL] [Abstract][Full Text] [Related]
6. Percutaneous radiofrequency ablation for small hepatocellular carcinoma in hepatic dome under MR-guidance: clinical safety and efficacy.
Chen J; Lin Z; Lin Q; Lin R; Yan Y; Chen J
Int J Hyperthermia; 2020; 37(1):192-201. PubMed ID: 32066293
[No Abstract] [Full Text] [Related]
7. Stereotactic radiofrequency ablation of tumors at the hepatic venous confluence.
Schullian P; Johnston E; Laimer G; Scharll Y; Putzer D; Eberle G; Kolbitsch C; Amann A; Stättner S; Bale R
HPB (Oxford); 2022 Jul; 24(7):1044-1054. PubMed ID: 34887174
[TBL] [Abstract][Full Text] [Related]
8. Safety and efficacy of stereotactic radiofrequency ablation for very large (≥8 cm) primary and metastatic liver tumors.
Schullian P; Johnston EW; Putzer D; Eberle G; Laimer G; Bale R
Sci Rep; 2020 Jan; 10(1):1618. PubMed ID: 32005871
[TBL] [Abstract][Full Text] [Related]
9. Frequency and risk factors for major complications after stereotactic radiofrequency ablation of liver tumors in 1235 ablation sessions: a 15-year experience.
Schullian P; Johnston E; Laimer G; Putzer D; Eberle G; Amann A; Effenberger M; Maglione M; Freund MC; Loizides A; Bale R
Eur Radiol; 2021 May; 31(5):3042-3052. PubMed ID: 33125554
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous Stereotactic Radiofrequency Ablation of Multiple (≥ 4) Liver Tumors: Feasibility, Safety, and Efficacy.
Schullian P; Putzer D; Eberle G; Laimer G; Bale R
J Vasc Interv Radiol; 2020 Jun; 31(6):943-952. PubMed ID: 32414570
[TBL] [Abstract][Full Text] [Related]
11. Stereotactic radiofrequency ablation of unresectable intrahepatic cholangiocarcinomas: a retrospective study.
Haidu M; Dobrozemsky G; Schullian P; Widmann G; Klaus A; Weiss H; Margreiter R; Bale R
Cardiovasc Intervent Radiol; 2012 Oct; 35(5):1074-82. PubMed ID: 22006031
[TBL] [Abstract][Full Text] [Related]
12. Stereotactic Radiofrequency Ablation of Liver Tumors in Octogenarians.
Schullian P; Putzer D; Silva MA; Laimer G; Kolbitsch C; Bale R
Front Oncol; 2019; 9():929. PubMed ID: 31608232
[No Abstract] [Full Text] [Related]
13. Technical efficacy and local recurrence after stereotactic radiofrequency ablation of 2653 liver tumors: a 15-year single-center experience with evaluation of prognostic factors.
Schullian P; Laimer G; Johnston E; Putzer D; Eberle G; Scharll Y; Widmann G; Kolbitsch C; Bale R
Int J Hyperthermia; 2022; 39(1):421-430. PubMed ID: 35227136
[TBL] [Abstract][Full Text] [Related]
14. Laparoscopy-Guided Transthoracic Transdiaphragmatic Radiofrequency Ablation for Hepatic Tumors Located Beneath the Diaphragm.
Tanaka K; Kojima T; Hiraguchi E; Hashida H; Noji T; Hirano S
J Laparoendosc Adv Surg Tech A; 2016 Mar; 26(3):180-4. PubMed ID: 26859794
[TBL] [Abstract][Full Text] [Related]
15. Stereotactic radiofrequency ablation (SRFA) of liver lesions: technique effectiveness, safety, and interoperator performance.
Widmann G; Schullian P; Haidu M; Bale R
Cardiovasc Intervent Radiol; 2012 Jun; 35(3):570-80. PubMed ID: 21671150
[TBL] [Abstract][Full Text] [Related]
16. [Percutaneous radiofrequency ablation with artificial hydrothorax for liver cancer in the hepatic dome].
Han Y; Yu L; Hao YZ; Yang M; Liu S; Deng YB; He LF; Cai JQ; Chen MH
Zhonghua Zhong Liu Za Zhi; 2012 Nov; 34(11):846-9. PubMed ID: 23291135
[TBL] [Abstract][Full Text] [Related]
17. Percutaneous radiofrequency ablation for hepatic tumors abutting the diaphragm: clinical assessment of the heat-sink effect of artificial ascites.
Nam SY; Rhim H; Kang TW; Lee MW; Kim YS; Choi D; Lee WJ; Park Y; Chang I; Lim HK
AJR Am J Roentgenol; 2010 Feb; 194(2):W227-31. PubMed ID: 20093579
[TBL] [Abstract][Full Text] [Related]
18. "Dual-scopic" intraoperative radiofrequency ablation for the treatment of a hepatic metastatic tumor located beneath the diaphragm.
Kang CM; Lee KH; Kim KM; Baik SH
Surg Laparosc Endosc Percutan Tech; 2008 Apr; 18(2):202-6. PubMed ID: 18427343
[TBL] [Abstract][Full Text] [Related]
19. Radiofrequency ablation for large hepatic hemangiomas: initial experience and lessons.
Gao J; Ke S; Ding XM; Zhou YM; Qian XJ; Sun WB
Surgery; 2013 Jan; 153(1):78-85. PubMed ID: 22853860
[TBL] [Abstract][Full Text] [Related]
20. Treatment strategy to optimize radiofrequency ablation for liver malignancies.
Chen MH; Wei Y; Yan K; Gao W; Dai Y; Huo L; Yin SS; Zhang H; Poon RT
J Vasc Interv Radiol; 2006 Apr; 17(4):671-83. PubMed ID: 16614151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]